SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


To: Howard Williams who wrote (11917)5/13/2013 7:59:49 AM
From: NTTG3 Recommendations  Read Replies (1) | Respond to of 13111
 
What is new here...Oh I see it... they are suggesting that progression free survival in non-nodal stage III is longer than stage IV disease as a result of PV-10...really? Not simply the result of natural disease history?

This is as meaningful as the strategy of trying to compare 'responders' and 'non-responders' in their PII trial dataset years ago.......

Long lists of re-cycled data presentations from 2010 to 1012 is churning, no progress there

The PH-10 discussion is simple smoke and mirrors

Jack, this is the stuff I am talking about